Covered recipient · General Payments record
NADA BEYDOUN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$929.05
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $294.54 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $88.95 | 1 |
| Indivior Inc. | $55.80 | 2 |
| Lilly USA, LLC | $31.59 | 2 |
| Novo Nordisk AS | $31.04 | 2 |
| Braeburn Inc. | $21.31 | 1 |
| Orexo US, Inc. | $19.73 | 1 |
| Astellas Pharma US Inc | $17.29 | 1 |
| ABBVIE INC. | $14.84 | 1 |
| GlaxoSmithKline, LLC. | $13.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.84 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103319118 | CMS |
| Astellas Pharma US Inc | $17.29 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139397861 | CMS |
| Braeburn Inc. | $21.31 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125605741 | CMS |
| Dexcom, Inc. | $88.95 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153324461 | CMS |
| GlaxoSmithKline, LLC. | $13.99 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115909579 | CMS |
| Indivior Inc. | $28.48 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144524375 | CMS |
| Indivior Inc. | $27.32 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144524377 | CMS |
| Lilly USA, LLC | $17.40 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135276306 | CMS |
| Lilly USA, LLC | $14.19 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135228550 | CMS |
| Novo Nordisk Inc | $13.84 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096910317 | CMS |
| Novo Nordisk Inc | $17.20 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097369850 | CMS |
| Orexo US, Inc. | $19.73 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136179978 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.